Obsidian Therapeutics enrols first patient in phase 1/2 Agni-01 study to evaluate Amsoki-cel in advanced melanoma

Join Pharma | Login

	Editorial


	A GOOD MOVE AGAINST COUNTERFEITERS
	Wednesday, August 5, 2026
	For the last several years, the Indian drug authorities have been facing the twin issues of quality of drugs produced in the country and distribution of counterfeit drugs in the Indian pharmaceutical market. Even though the
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	Obsidian Therapeutics enrols first patient in phase 1/2 Agni-01 study to evaluate Amsoki-cel in advanced melanoma
17:00 [IST]	Emergent BioSolutions highlights for a cross-sector collaboration against biological threats in evolving global security environ
16:00 [IST]	Kodiak Sciences completes enrollment in phase 3 PEAK trial of KSI-101 for macular edema secondary to inflammation
15:00 [IST]	Evotec and Odyssey Therapeutics ink AI-enabled R&D collaboration in autoimmune and inflammatory diseases
14:00 [IST]	Dispatch Bio begins patient dosing in phase 1 study of DISP-10, a novel investigational immunotherapy, in advanced gastrointestinal cancers
13:45 [IST]	NHA achieves milestone with 25 crore OPD registrations through ABHA-based Scan and Register Service

more news >>

TOP NEWS


08:00 [IST]	Panel recommends measures to increase public participation in retail price fixation of new drugs
08:00 [IST]	Maharashtra FDA issues statewide compliance order for blood centres to strengthen blood safety
08:00 [IST]	Kerala high court division bench closes discount pharmacy appeal as infructuous
08:00 [IST]	Healthcare sector’s future in India will be defined by trust, not technology: Ayush Jain
08:00 [IST]	APPC facing fire over retrospective penalties, portal backlogs, and misuse of statutory powers
08:00 [IST]	Microbiome therapeutics emerging as future engine of drug discovery & personalized healthcare: Dr Debojyoti Dhar

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Axplora's sustainability strategy substantiated by SBTi as company accelerates action across its manufacturing network
17:40 [IST]	Neuland Laboratories Q1 net profit stood at Rs.147.4 crore
17:30 [IST]	9th India Medical Device 2026 commences in New Delhi
17:20 [IST]	India's medical device industry projected to reach $250 billion by 2047: FICCI-DUA Consulting Report
17:15 [IST]	NIO study reports smartphone-based AI system, sees high accuracy in detecting eye diseases
16:15 [IST]	PayU partners with Marg ERP to simplify digital Payment collections for pharma distributors and MSMEs

more news >>

INTERVIEW


Uzbekistan offers one of the most dynamic and strategically positioned pharmaceutical markets in Eurasia: Abdulla Azizov
Abdulla Azizov, Chairman of the Medical and Pharmaceutical Industry Development Agency and the First Deputy Minister of Health of the Republic of Uzbekistan

Past Interviews...

	What's New?

Neuland Laboratories Q1 net profit stood at Rs.147.4 crore Lupin Q1 net profit up 16% Emcure Pharma Q1 net profit rises 36% Aurobindo Pharma Q1 revenue up 16% YoY Metropolis Healthcare Q1 net profit rises 26%

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers